Diabetes mellitus en el embarazo

1. Egan AM, Dow ML, Vella A. A review of the pathophysiology and management of diabetes in pregnancy. Mayo Clin Proc. 2020; 95 (12): 2734–2746

2. Azar M, Stoner JA, Dao HD, et al. Epidemiology of dysglycemia in pregnant Oklahoma American Indian women. J Clin Endocrinol Metab. 2015;100(8):2996–3003

3. Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020;8(3):226–238

4. Dendup T, Feng X, Clingan S, Astell-Burt T. Environmental risk factors for developing type 2 diabetes mellitus: A systematic review. Int J Environ Res Public Health. 2018;15(1):78

5. Deputy NP, Kim SY, Conrey EJ, Bullard KM. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth – United States 2012–2016. MMWR Morb Mortal Wkly Rep. 2018;67(43):1201–1207

6. Shub A, Lappas M. Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of disease-A review. Prenat Diagn. 2020;40(9):1092–1098

7. Kim SY, Saraiva C, Curtis M, Wilson HG, Troyan J, Sharma AJ. Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007–2009. Am J Public Health. 2013;103(10): e65–e72

8. Moyer VA; U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventative Services Task Force recommendation statement. Ann Intern Med. 2014;160(6):414–420

9. Egan AM, Galjaard S, Maresh MJA, et al. A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes. Diabetologia. 2017;60(7):1190–1196

10. Costrini NV, Kalkhoff RK. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest. 1971;50(5):992–999

11. Powe CE, Huston Presley LP, Locascio JJ, Catalano PM. Augmented insulin secretory response in early pregnancy. Diabetologia. 2019;62(8):1445–1452

12. Panaitescu AM, Peltecu G. Gestational diabetes: Obstetric perspective. Acta Endocrinol (Buchar). 2016;12(3):331–334

13. Agarwal MM, Boulvain M, Coetzee E, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341–363

14. Metzger BE, Gabbe SG, Persson B, et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682

15. Van Dorsten JP, Dodson WC, Espeland MA, et al. NIH consensus development conference statement: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements. 2013; 29:1

16. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 201: pregestational diabetes mellitus. Obstet Gynecol. 2018;132(6): e228–e248

17. ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131: e49–e64

18. Schaefer-Graf U, Napoli A, Nolan CJ; Diabetic Pregnancy Study Group. Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia. 2018;61(5):1012–1021

19. American Diabetes Association. 14. Management of diabetes in pregnancy: Standards of medical care in diabetes – 2020. Diabetes Care. 2020;43 (suppl 1): S183–S192

20. Draznin B, Aroda VR, Bakris G, et al; American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: Standards of medical care in diabetes 2022. Diabetes Care. 2022;45 (suppl 1): S232–S243

21. Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019;15(11):635–650

22. Tremblay J, Hamet P. Environmental and genetic contributions to diabetes. Metabolism. 2019;100S:153952

23. Harjutsalo V, Reunanen A, Tuomilehto J. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes. 2006;55(5):1517–1524

24. Bengtson AM, Dice ALE, Clark MA, Gutman R, Rouse D, Werner E. Predicting progression from gestational diabetes to impaired glucose tolerance using peridelivery data: an observational study. Am J Perinatol. 2022 doi: 10.1055/a-1877-9587

25. Murphy HR, Bell R, Cartwright C, et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study. Diabetologia. 2017;60(9):1668–1677

26. Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59(7):1396–1399

27. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care. 2009;32(11):2005–2009

28. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39(3): 225–231

29. Gabbay-Benziv R, Reece EA, Wang F, Yang P. Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World J Diabetes. 2015;6(3):481–488

30. Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c $5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953–2959

31. Okubo H, Crozier SR, Harvey NC, et al. Maternal dietary glycemic index and glycemic load in early pregnancy are associated with offspring adiposity in childhood: The Southampton Women’s Survey. Am J Clin Nutr. 2014;100(2):676–683

32. Herrera E, Desoye G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Investig. 2016;26(2):109–127

33. Cyganek K, Skupien J, Katra B, et al. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control. Endocrine. 2017;55(2):447–455

34. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191(3):964–968

35. Benedetti TJ, Gabbe SG. Shoulder dystocia. A complication of fetal macrosomia and prolonged second stage of labor with midpelvic delivery. Obstet Gynecol. 1978;52(5):526–529

36. Lampl M, Jeanty P. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. Am J Hum Biol. 2004;16(3):237–263

37. Klemetti MM, Laivuori H, Tikkanen M, Nuutila M, Hiilesmaa V, Teramo K. White’s classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study. Diabetologia. 2016;59(1):92–100

38. Lauszus FF, Fuglsang J, Flyvbjerg A, Klebe JG. Preterm delivery in normoalbuminuric, diabetic women without preeclampsia: the role of metabolic control. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):144–149

39. Starikov R, Dudley D, Reddy UM. Stillbirth in the pregnancy complicated by diabetes. Curr Diab Rep. 2015;15(3):11

40. Camprubi Robles M, Campoy C, Garcia Fernandez L, Lopez-Pedrosa JM, Rueda R, Martin MJ. Maternal diabetes and cognitive performance in the offspring: a systematic review and meta-analysis. PLoS One. 2015;10(11): e0142583

41. Wahabi HA, Alzeidan RA, Esmaeil SA. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC Public Health. 2012; 12:792

42. Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013;36(7):1877–1883

43. Finneran MM, Kiefer MK, Ware CA, et al. The use of longitudinal hemoglobin A1c values to predict adverse obstetric and neonatal outcomes in pregnancies complicated by pregestational diabetes. Am J Obstet Gynecol MFM. 2020;2(1):100069

44. Cahill AG, Tuuli MG, Colvin R, Cade WT, Macones GA. Markers of glycemic control and neonatal morbidity in high-risk insulin resistant pregnancies. Am J Perinatol. 2016;33(2):151–156